Combining Bevacizumab with Endostatin Gets Better Antitumor Efficacy in Vivo 
in Lung Cancer Animal Model

Combining Bevacizumab with Endostatin Gets Better Antitumor Efficacy in Vivo 
in Lung Cancer Animal Model

Background and objective The aim of this study is to investigate difference of antiangiogenesis ablility and interaction about bevacizumab and endostatin in vivo in lung cancer animal model. Methods First, we construct a Balb/c mice model with A549 lung adenocarcinoma cell. Then, we divide the mice...

Full description

Bibliographic Details
Main Authors: Niu NIU, Baolan LI, Chaoyang LIU, Ying HU, Xuebing LI, Jie LI, Heling SHI, Haiqing ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-02-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Antiangiogenesis
Endostatin
Bevacizumab
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.01

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2013.02.01

Similar Items